Boehringer Ingelheim International GmbH: clinical-trial pipeline
Boehringer Ingelheim International GmbH is the sponsor of 2,301 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 102 are not yet finished and 11 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials102
Phase 2/3 and 3404
Countries79
New in 90 days11
Trials by phase
| Phase | Trials |
|---|---|
| Phase 1 | 1,075 |
| Phase 3 | 390 |
| Not applicable | 384 |
| Phase 2 | 295 |
| Phase 4 | 126 |
| Phase 1/2 | 16 |
| Phase 2/3 | 14 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 2,010 |
| Terminated | 154 |
| Recruiting | 47 |
| Active, not recruiting | 39 |
| Withdrawn or not authorised | 31 |
| Not yet recruiting | 16 |
| Suspended or halted | 4 |
Condition areas
| Area | Trials |
|---|---|
| Respiratory | 384 |
| Oncology | 267 |
| Cardiovascular | 258 |
| Metabolic and endocrine (diabetes, obesity) | 197 |
| Infectious disease and vaccines | 102 |
| Gastroenterology and liver | 92 |
| Immunology and rheumatology | 83 |
| Neurology | 82 |
| Nephrology and urology | 68 |
| Rare and genetic diseases | 50 |
| Dermatology | 36 |
| Psychiatry and mental health | 28 |
Countries
| Country | Trials |
|---|---|
| Germany | 759 |
| United States | 524 |
| Spain | 322 |
| Japan | 299 |
| France | 291 |
| Belgium | 288 |
| Canada | 279 |
| United Kingdom | 266 |
| Netherlands | 257 |
| Italy | 241 |
| South Korea | 218 |
| Poland | 178 |
| China | 171 |
| Australia | 167 |
| Austria | 165 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-12 | New trial posted | A study to compare how survodutide is taken up by the body when given in 2 formulations t… |
| 2026-10-05 | New trial posted | A study to test how well different doses of BI 3821001 are tolerated by healthy people |
| 2026-10-02 | New trial posted | SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweig… |
| 2026-10-01 | New trial posted | A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Pat… |
| 2026-09-30 | New trial posted | ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Func… |
| 2026-09-30 | New trial posted | SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Ov… |
| 2026-09-29 | New trial posted | A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagl… |
| 2026-09-28 | New trial posted | A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Ce… |
| 2026-09-23 | New trial posted | A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in T… |
| 2026-08-27 | New trial posted | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammato… |
| 2026-08-27 | New trial posted | A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as T… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05846516 | A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenoc… | Phase 1 | Active, not recruiting | Switzerland, Germany, Spain, France +1 |
| NCT06238622 | A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took P… | Phase 3 | Active, not recruiting | Argentina, Austria, Australia, Belgium +39 |
| NCT05916313 | A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That… | Phase 1 | Recruiting | Austria, Switzerland, Germany, Spain +2 |
| 2023-509566-38-00 | Beamion BCGC-1: A Phase Ib dose escalation and Phase II dose optimization, randomized, open-label, multicente… | Phase 1/2 | Recruiting | Belgium, Germany, Spain, France +1 |
| NCT06962852 | A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Stu… | Phase 1/2 | Active, not recruiting | Spain, France, United Kingdom, Italy +1 |
| NCT05471856 | A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People Wit… | Phase 1 | Recruiting | Spain, United Kingdom, Japan, South Korea +2 |
| 2024-512504-19-00 | A study to test different doses of BI 1831169 alone and in combination with an anti-PD-1 antibody in people w… | Phase 1 | Not yet recruiting | Austria, Belgium, Germany, Spain +2 |
| NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | Phase 3 | Active, not recruiting | Argentina, Australia, Belgium, Brazil +16 |
| 2024-514034-20-00 | A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advance… | Phase 1 | Active, not recruiting | Netherlands |
| 2024-513549-36-01 | A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH | Phase 1 | Recruiting | Belgium |
| NCT04429087 | A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrin… | Phase 1 | Active, not recruiting | Germany, Spain, Japan, United States |
| NCT06581432 | Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterati… | Phase 2 | Recruiting | Australia, Belgium, Canada, China +12 |
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | Phase 3 | Recruiting | Argentina, Australia, Belgium, Bulgaria +25 |
| NCT04886804 | Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Can… | Phase 1 | Active, not recruiting | Austria, Australia, Belgium, China +14 |
| NCT06321302 | A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy | Phase 2 | Recruiting | Germany, Spain, United Kingdom, Hungary +5 |
| NCT06619509 | A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous… | Phase 2 | Active, not recruiting | Argentina, Australia, Belgium, Canada +16 |
| NCT05202353 | A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Recepto… | Phase 1 | Active, not recruiting | Netherlands |
| NCT06745297 | A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated | Phase 1 | Recruiting | Germany |
| NCT06636656 | A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis | Phase 2 | Recruiting | Belgium, Czechia, Poland, Serbia +2 |
| NCT06632457 | LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH… | Phase 3 | Recruiting | Argentina, Austria, Australia, Belgium +31 |
| NCT06632444 | LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Mo… | Phase 3 | Recruiting | Argentina, Austria, Australia, Belgium +31 |
| NCT06878365 | A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies | Phase 1 | Active, not recruiting | Belgium, Germany, Spain, France +5 |
| NCT06806592 | A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases | Phase 3 | Active, not recruiting | Austria, Australia, Switzerland, China +12 |
| NCT06806852 | A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab… | Phase 1 | Active, not recruiting | Australia, Bulgaria, Brazil, Switzerland +17 |
| NCT06935370 | A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Fai… | Phase 3 | Recruiting | Argentina, Belgium, Bulgaria, Brazil +24 |
Website: boehringer-ingelheim.com. All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Boehringer Ingelheim International GmbH clinical trials: 102 open, 404 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/boehringer-ingelheim-com/, data as of 2026-10-25.